Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.

Company profile
Ticker
ALC
Exchange
Website
CEO
David Endicott
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
ALC stock data
Analyst ratings and price targets
Current price
Average target
$77.50
Low target
$69.00
High target
$85.00
Mizuho
Initiated
$85.00
BTIG
Maintains
$78.00
Morgan Stanley
Maintains
$78.00
Citigroup
Maintains
$69.00
Latest filings (excl ownership)
6-K
Alcon Reports Third Quarter 2022 Results
15 Nov 22
DEFA14A
Additional proxy soliciting materials
22 Aug 22
6-K
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
22 Aug 22
6-K
Alcon Reports Second Quarter 2022 Results
9 Aug 22
SD
Conflict minerals disclosure
26 May 22
6-K
Alcon Reports First Quarter 2022 Results
10 May 22
6-K
Alcon Publishes Agenda for 2022 Annual General Meeting
24 Mar 22
6-K
Current report (foreign)
15 Feb 22
20-F
2021 FY
Annual report (foreign)
15 Feb 22
6-K
Alcon Reports Fourth Quarter and Full Year 2021 Results
15 Feb 22
Transcripts
ALC
Earnings call transcript
2022 Q3
16 Nov 22
ALC
Earnings call transcript
2022 Q2
10 Aug 22
ALC
Earnings call transcript
2022 Q1
11 May 22
ALC
Earnings call transcript
2021 Q2
18 Aug 21
ALC
Earnings call transcript
2021 Q1
5 May 21
ALC
Earnings call transcript
2020 Q4
24 Feb 21
ALC
Earnings call transcript
2020 Q3
11 Nov 20
Latest ownership filings
SC 13G
BlackRock Inc.
8 Sep 22
SC 13G/A
WCM INVESTMENT MANAGEMENT, LLC
10 Feb 22
SC 13G/A
Capital Research Global Investors
16 Feb 21
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
16 Feb 21
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
10 Sep 20
SC 13G
Beneficial ownership report
14 Feb 20
SC 13G
Alcon Inc
10 Jan 20
SC 13D/A
NOVARTIS AG
25 Mar 11
SC 13D/A
NOVARTIS AG
15 Mar 11
SC 13D/A
NOVARTIS AG
1 Mar 11
Financial summary
Quarter (USD) | Dec 21 | Dec 20 | Dec 19 | Mar 11 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Mar 11 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2022
43.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 527 |
Opened positions | 42 |
Closed positions | 94 |
Increased positions | 159 |
Reduced positions | 210 |
13F shares | Current |
---|---|
Total value | 13.07 bn |
Total shares | 214.92 mm |
Total puts | 1.33 mm |
Total calls | 1.59 mm |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 16.19 mm | $941.92 mm |
Aristotle Capital Management | 14.39 mm | $837.21 mm |
Credit Suisse | 12.98 mm | $755.17 mm |
Clearbridge Advisors | 11.48 mm | $668.02 mm |
Harding Loevner | 10.13 mm | $589.23 mm |
Zurcher Kantonalbank | 6.89 mm | $407.01 mm |
T. Rowe Price Investment Management | 6.35 mm | $369.51 mm |
Brown Brothers Harriman & Co | 5.75 mm | $334.61 mm |
Ako Capital | 5.75 mm | $337.05 mm |
WCM Investment Management | 5.25 mm | $298.97 mm |
News
This Favorable Sign Appears On Alcon's Chart
24 Jan 23
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
22 Dec 22
Mizuho Initiates Coverage On Alcon with Buy Rating, Announces Price Target of $85
22 Dec 22
5 Analysts Have This to Say About Alcon
21 Dec 22
BTIG Maintains Buy on Alcon, Raises Price Target to $78
21 Dec 22
Press releases
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
5 Jan 23
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
28 Dec 22
Alcon Prices US$1.3 Billion Senior Notes Offering
29 Nov 22
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business
22 Nov 22
Thinking about trading options or stock in Target, NVIDIA, Lowe's Companies, NetEase, or Alcon?
16 Nov 22